Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.009x

Based on the latest financial reports, Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) has a cash flow conversion efficiency ratio of -0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-15.07 Million ≈ $-2.21 Million USD) by net assets (CN¥1.74 Billion ≈ $254.21 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Jiangsu Lianhuan Pharmaceutical Co Ltd net asset quality index to measure how much of total assets are equity-financed.

Jiangsu Lianhuan Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2002–2024)

This chart illustrates how Jiangsu Lianhuan Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 600513 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Jiangsu Lianhuan Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jiangsu Lianhuan Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Grupo Supervielle S.A. B
BA:SUPV
0.176x
Companhia de Saneamento do Paraná - SANEPAR
SA:SAPR3
0.414x
Golden Entertainment Inc
NASDAQ:GDEN
0.062x
Neto Malinda
TA:NTML
-0.090x
UBISOFT ENTMT ADR 1/5
F:UEN0
N/A
Lg Electronics Pref
KO:066575
0.061x
Pakuwon Jati Tbk
JK:PWON
0.026x
Surge Energy Inc.
TO:SGY
0.086x

Annual Cash Flow Conversion Efficiency for Jiangsu Lianhuan Pharmaceutical Co Ltd (2002–2024)

The table below shows the annual cash flow conversion efficiency of Jiangsu Lianhuan Pharmaceutical Co Ltd from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) total market value.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥1.58 Billion
≈ $230.80 Million
CN¥10.77 Million
≈ $1.58 Million
0.007x -93.56%
2023-12-31 CN¥1.52 Billion
≈ $222.03 Million
CN¥160.70 Million
≈ $23.52 Million
0.106x +17.35%
2022-12-31 CN¥1.41 Billion
≈ $206.87 Million
CN¥127.59 Million
≈ $18.67 Million
0.090x -16.44%
2021-12-31 CN¥1.28 Billion
≈ $187.44 Million
CN¥138.34 Million
≈ $20.24 Million
0.108x +38.86%
2020-12-31 CN¥1.18 Billion
≈ $172.97 Million
CN¥91.94 Million
≈ $13.45 Million
0.078x +954.26%
2019-12-31 CN¥1.08 Billion
≈ $158.63 Million
CN¥-9.87 Million
≈ $-1.44 Million
-0.009x +90.63%
2018-12-31 CN¥946.61 Million
≈ $138.52 Million
CN¥-92.00 Million
≈ $-13.46 Million
-0.097x -2447.48%
2017-12-31 CN¥878.23 Million
≈ $128.51 Million
CN¥3.64 Million
≈ $532.06K
0.004x -95.13%
2016-12-31 CN¥827.25 Million
≈ $121.05 Million
CN¥70.28 Million
≈ $10.28 Million
0.085x +5.99%
2015-12-31 CN¥774.88 Million
≈ $113.39 Million
CN¥62.12 Million
≈ $9.09 Million
0.080x -49.91%
2014-12-31 CN¥434.25 Million
≈ $63.54 Million
CN¥69.50 Million
≈ $10.17 Million
0.160x +73.13%
2013-12-31 CN¥402.11 Million
≈ $58.84 Million
CN¥37.17 Million
≈ $5.44 Million
0.092x +91.22%
2012-12-31 CN¥350.42 Million
≈ $51.28 Million
CN¥16.94 Million
≈ $2.48 Million
0.048x -34.00%
2011-12-31 CN¥327.61 Million
≈ $47.94 Million
CN¥24.00 Million
≈ $3.51 Million
0.073x +168.56%
2010-12-31 CN¥308.95 Million
≈ $45.21 Million
CN¥8.43 Million
≈ $1.23 Million
0.027x -42.05%
2009-12-31 CN¥293.89 Million
≈ $43.01 Million
CN¥13.83 Million
≈ $2.02 Million
0.047x -23.99%
2008-12-31 CN¥281.68 Million
≈ $41.22 Million
CN¥17.44 Million
≈ $2.55 Million
0.062x +108.09%
2007-12-31 CN¥269.97 Million
≈ $39.51 Million
CN¥8.03 Million
≈ $1.18 Million
0.030x -23.97%
2006-12-31 CN¥259.20 Million
≈ $37.93 Million
CN¥10.14 Million
≈ $1.48 Million
0.039x +162.08%
2005-12-31 CN¥255.97 Million
≈ $37.46 Million
CN¥3.82 Million
≈ $559.35K
0.015x +10.21%
2004-12-31 CN¥250.42 Million
≈ $36.64 Million
CN¥3.39 Million
≈ $496.50K
0.014x +125.29%
2003-12-31 CN¥246.22 Million
≈ $36.03 Million
CN¥-13.19 Million
≈ $-1.93 Million
-0.054x -123.77%
2002-12-31 CN¥85.26 Million
≈ $12.48 Million
CN¥19.22 Million
≈ $2.81 Million
0.225x --

About Jiangsu Lianhuan Pharmaceutical Co Ltd

SHG:600513 China Drug Manufacturers - Specialty & Generic
Market Cap
$739.77 Million
CN¥5.06 Billion CNY
Market Cap Rank
#10253 Global
#2715 in China
Share Price
CN¥17.71
Change (1 day)
+2.49%
52-Week Range
CN¥14.08 - CN¥30.75
All Time High
CN¥30.75
About

Jiangsu Lianhuan Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceuticals, preparations, and active pharmaceutical ingredients (API) products in China and internationally. The company offers clopidogrel bisulfate tablets, doxycycline hydrochloride, azithromycin, milrinone, dapoxetine hydrochloride, tadalafil, and betasine besylate tablets, as well as aprili… Read more